Recall
FDAHealthJune 20, 2025

Lupin Pharmaceuticals Inc. — Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin L

⚠️ Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 20, 2025

Product was distributed nationwide within the United States.

What's affected?

Product
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01
UPC
0368180519010
Lot code
QA01081

Additional details

Lot #: QA01081, Exp. Date April 2027

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 58,968 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.